A Study on Cytomegalovirus (CMV) Infection Outcomes Among Hematopoietic Stem Cell Transplant (HSCT) Participants in Europe and Canada

Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study

NCT01077908 ·Status: COMPLETED ·Phase: PHASE3

A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era.

NCT02067169 ·Status: COMPLETED

A Trial to Study How the Body Fights Off Cytomegalovirus (CMV) in Hematopoietic Transplant Recipients.

NCT00273143 ·Status: COMPLETED

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

NCT02784756 ·Status: COMPLETED ·Phase: NA

Evaluation of CMV/EBV-CMI in Haploid HSCT

NCT06554197 ·Status: RECRUITING

A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients

NCT01769170 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir

NCT02931539 ·Status: COMPLETED ·Phase: PHASE3

Prospective Multicentric Study of Cytomegalovirus Resistance in Transplant Patients and Bone Marrow Recipients

NCT01008540 ·Status: COMPLETED ·Phase: NA

Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients

NCT00497796 ·Status: COMPLETED ·Phase: PHASE3

Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation

NCT01326273 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

A Study of Cytomegalovirus Disease Epidemiology in Pediatric and Adult Liver Transplant Recipients in China

NCT05958186 ·Status: COMPLETED

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

NCT00509691 ·Status: COMPLETED ·Phase: PHASE1

The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection.

NCT00275665 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells

NCT03798301 ·Status: TERMINATED ·Phase: PHASE1

Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy

NCT04056533 ·Status: RECRUITING ·Phase: PHASE2

Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation

NCT06916195 ·Status: RECRUITING

Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients

NCT01558037 ·Status: COMPLETED

Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients

NCT03210090 ·Status: UNKNOWN

Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)

NCT00330018 ·Status: COMPLETED ·Phase: PHASE3

Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients

NCT01611974 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

NCT05319353 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients

NCT02268526 ·Status: COMPLETED ·Phase: PHASE2

Cell-mediated Immunity for Prevention of CMV Disease

NCT02538172 ·Status: COMPLETED ·Phase: NA

Dried Blood Spot Testing of CMV Detection in HCT Recipients

NCT03910478 ·Status: COMPLETED ·Phase: NA

Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus

NCT01325636 ·Status: COMPLETED ·Phase: PHASE1/PHASE2